TELEMEDICINE IN DIABETES MELLITUS, THE NEW ROAD AHEAD
DOI:
https://doi.org/10.19230/jonnpr.4804Abstract
Introduction: Diabetes Mellitus is a very prevalent chronic disease worldwide that generates a large number of care processes and a complex approach, assuming a significant percentage of health spending. That is why the need arises to develop a system that allows for more efficient management of these patients while ensuring continuous quality care, resulting in telemedicine as a valid alternative.
Objectives: This study aims to analyze the effectiveness of interventions based on telemedicine in the management of patients with Diabetes Mellitus compared to standard care. The performance of these new interventions in patients with type 1 and type 2 Diabetes Mellitus is compared, evaluating the improvement of clinical and analytical parameters, quality of life and cost reduction thanks to their use.
Results: A review of the main search engines and databases was carried out. Among the publications used, it was possible to find a significant reduction in HbA1c levels in both types of diabetes, an increase in self-control and self-efficacy, an improvement in variable quality of life according to the questionnaire, and finally, a reduction in care costs.
Conclusion: Telemedicine stands as an effective and valid alternative to regular care for these patients. More research is needed in the future to be able to unify the different systems, thus giving rise to a universal tool.
Downloads
References
Wondifraw H. Classification, Pathophysiology, Diagnosis and Management of Diabetes Mellitus. J Diabetes Metab. 1 de enero de 2015;06.
American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021. Diabetes Care. 4 de diciembre de 2020;44(Supplement_1):S15-33.
Ruiz-Ramos M, Escolar-Pujolar A, Mayoral-Sánchez E, Corral-San Laureano F, Fernández-Fernández I. La diabetes mellitus en España: mortalidad, prevalencia, incidencia, costes económicos y desigualdades. Gac Sanit. marzo de 2006;20:15-24.
IDF_Atlas_10th_Edition_2021.pdf [Internet]. [citado 22 de abril de 2022]. Disponible en: https://diabetesatlas.org/idfawp/resource-files/2021/07/IDF_Atlas_10th_Edition_2021.pdf
Ibáñez J, Rovira E, Ribera J. TELEMEDICINA E INNOVACIÓN EN DIABETES. :38.
Rojo-Martínez G, Valdés S, Soriguer F, Vendrell J, Urrutia I, Pérez V, et al. Incidence of diabetes mellitus in Spain as results of the nation-wide cohort di@bet.es study. Sci Rep. diciembre de 2020;10(1):2765.
Saila O. MINISTERIO DE SANIDAD Y CONSUMO. :181.
Paré G, Jaana M, Sicotte C. Systematic Review of Home Telemonitoring for Chronic Diseases: The Evidence Base. J Am Med Inform Assoc JAMIA. 2007;14(3):269-77.
WHO Global Observatory for eHealth. mHealth: new horizons for health through mobile technologies: second global survey on eHealth. 2011 [citado 22 de abril de 2022]; Disponible en: https://apps.who.int/iris/handle/10665/44607
Escobar-Curbelo L, Franco-Moreno AI. Application of Telemedicine for the Control of Patients with Acute and Chronic Heart Diseases. Telemed E-Health. 1 de noviembre de 2019;25(11):1033-9.
Gunasekeran DV, Ting DSW, Tan GSW, Wong TY. Artificial intelligence for diabetic retinopathy screening, prediction and management. Curr Opin Ophthalmol. septiembre de 2020;31(5):357-65.
Peterson CB, Hamilton C, Hasvold P. From innovation to implementation: eHealth in the WHO European region. Copenhagen, Denmark: WHO Regional Office for Europe; 2016. 98 p.
Kirwan M, Vandelanotte C, Fenning A, Duncan MJ. Diabetes Self-Management Smartphone Application for Adults With Type 1 Diabetes: Randomized Controlled Trial. J Med Internet Res. 13 de noviembre de 2013;15(11):e235.
Zhai Y kai, Zhu W jun, Cai Y ling, Sun D xu, Zhao J. Clinical- and Cost-effectiveness of Telemedicine in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis. Medicine (Baltimore). 2 de diciembre de 2014;93(28):e312.
SESCS_2016_FreeStyleLibre_OK.pdf [Internet]. [citado 24 de abril de 2022]. Disponible en: https://www3.gobiernodecanarias.org/sanidad/scs/content/00fe0638-2c30-11e8-9b62-f196074e3cc3/SESCS_2016_FreeStyleLibre_OK.pdf
So CF, Chung JW. Telehealth for diabetes self-management in primary healthcare: A systematic review and meta-analysis. J Telemed Telecare. junio de 2018;24(5):356-64.
Lee SWH, Chan CKY, Chua SS, Chaiyakunapruk N. Comparative effectiveness of telemedicine strategies on type 2 diabetes management: A systematic review and network meta-analysis. Sci Rep. 4 de octubre de 2017;7:12680.
Warren R, Carlisle K, Mihala G, Scuffham PA. Effects of telemonitoring on glycaemic control and healthcare costs in type 2 diabetes: A randomised controlled trial. J Telemed Telecare. octubre de 2018;24(9):586-95.
Tchero H, Kangambega P, Briatte C, Brunet-Houdard S, Retali GR, Rusch E. Clinical Effectiveness of Telemedicine in Diabetes Mellitus: A Meta-Analysis of 42 Randomized Controlled Trials. Telemed E-Health. julio de 2019;25(7):569-83.
Lee JY, Lee SWH. Telemedicine Cost–Effectiveness for Diabetes Management: A Systematic Review. Diabetes Technol Ther. julio de 2018;20(7):492-500.
Xu T, Pujara S, Sutton S, Rhee M. Telemedicine in the Management of Type 1 Diabetes. Prev Chronic Dis. 25 de enero de 2018;15:170168.
Kim EK, Kwak SH, Jung HS, Koo BK, Moon MK, Lim S, et al. The Effect of a Smartphone-Based, Patient-Centered Diabetes Care System in Patients With Type 2 Diabetes: A Randomized, Controlled Trial for 24 Weeks. Diabetes Care. 1 de enero de 2019;42(1):3-9.
Borries TM, Dunbar A, Bhukhen A, Rismany J, Kilham J, Feinn R, et al. The impact of telemedicine on patient self-management processes and clinical outcomes for patients with Types I or II Diabetes Mellitus in the United States: A scoping review. Diabetes Metab Syndr Clin Res Rev. 1 de marzo de 2019;13(2):1353-7.
Correia JC, Meraj H, Teoh SH, Waqas A, Ahmad M, Lapão LV, et al. Telemedicine to deliver diabetes care in low- and middle-income countries: a systematic review and meta-analysis. Bull World Health Organ. 1 de marzo de 2021;99(3):209-219B.
Millan-Ferro A, Garcia-Dolagaray G, Gautam S, Caballero AE, Mitri J. Impact of Monthly A1C Values Obtained at Home on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial. Clin Diabetes Publ Am Diabetes Assoc. julio de 2020;38(3):230-9.
Eberle C, Stichling S. Clinical Improvements by Telemedicine Interventions Managing Type 1 and Type 2 Diabetes: Systematic Meta-review. J Med Internet Res. 19 de febrero de 2021;23(2):e23244.
Michaud TL, Ern J, Scoggins D, Su D. Assessing the Impact of Telemonitoring-Facilitated Lifestyle Modifications on Diabetes Outcomes: A Systematic Review and Meta-Analysis. Telemed E-Health. 1 de febrero de 2021;27(2):124-36.
Timpel P, Oswald S, Schwarz PEH, Harst L. Mapping the Evidence on the Effectiveness of Telemedicine Interventions in Diabetes, Dyslipidemia, and Hypertension: An Umbrella Review of Systematic Reviews and Meta-Analyses. J Med Internet Res. 18 de marzo de 2020;22(3):e16791.
De Groot J, Wu D, Flynn D, Robertson D, Grant G, Sun J. Efficacy of telemedicine on glycaemic control in patients with type 2 diabetes: A meta-analysis. World J Diabetes. 15 de febrero de 2021;12(2):170-97.
Oyagüez I, Gómez-Peralta F, Artola S, Carrasco FJ, Carretero-Gómez J, García-Soidan J, et al. Cost Analysis of FreeStyle Libre® 2 System in Type 2 Diabetes Mellitus Population. Diabetes Ther. septiembre de 2021;12(9):2329-42.
Oyagüez I, Merino-Torres JF, Brito M, Bellido V, Cardona-Hernandez R, Gomez-Peralta F, et al. Cost analysis of the flash monitoring system (FreeStyle Libre 2) in adults with type 1 diabetes mellitus. BMJ Open Diabetes Res Care. julio de 2020;8(1):e001330.
Downloads
Published
Issue
Section
License
All accepted originals remain the property of JONNPR. In the event of publication, the authors exclusively transfer their rights of reproduction, distribution, translation and public communication (by any sound, audiovisual or electronic medium or format) of their work. To do so, the authors shall sign a letter transferring these rights when sending the paper via the online manuscript management system.
The articles published in the journal are freely used under the terms of the Creative Commons BY NC SA license, therefore.
You are free to:
Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial — You may not use the material for commercial purposes.
ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
